Summary

Market Overview
The United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market was valued at USD 3.70 billion in 2024 and is projected to reach USD 5.13 billion by 2030, growing at a CAGR of 5.55% during the forecast period. This market encompasses essential medical technologies used to diagnose, manage, and treat various cardiac conditions. Cardiac monitoring devices, including ECG machines, Holter monitors, and event recorders, play a vital role in detecting arrhythmias and monitoring the heart's electrical activity over time. Meanwhile, cardiac rhythm management devices—such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices—are instrumental in correcting irregular heart rhythms, preventing sudden cardiac arrest, and optimizing cardiac performance, particularly in heart failure patients.
With cardiovascular diseases (CVDs) remaining the leading cause of death across the U.S., and with a growing prevalence of obesity, diabetes, and hypertension, the need for effective cardiac monitoring and rhythm management solutions continues to rise. The aging population further contributes to increased demand, prompting healthcare providers to invest in advanced cardiac technologies aimed at improving outcomes and enhancing patient quality of life.
Key Market Drivers
Growing Burden of Cardiovascular Disorders
The rising incidence of cardiovascular disorders is a primary driver of market growth in the United States. CVD remains the leading cause of death nationwide, affecting one in three adults and contributing to a death every 33 seconds. Conditions such as coronary artery disease, stroke, and heart failure place a significant burden on healthcare systems and necessitate timely diagnosis and intervention.
Cardiac monitoring devices enable continuous assessment of heart function and help detect irregularities that may lead to critical complications. Similarly, cardiac rhythm management devices offer therapeutic solutions that restore normal rhythm and reduce the risk of sudden cardiac events. As the population ages and lifestyle-related health issues become more widespread, demand for these technologies is expected to increase, especially in hospitals and specialized cardiac care centers aiming to deliver high-quality and preventive cardiac care.
Key Market Challenges
Effects of Therapeutic Radiation on Implantable Cardiac Rhythm Devices
A significant challenge facing the market is the vulnerability of implantable cardiac rhythm devices to interference from therapeutic radiation, commonly used in cancer treatments. Radiation exposure can compromise device function, posing serious safety risks for patients relying on pacemakers or defibrillators.
This has led to a shift in patient preference and physician recommendations, with growing interest in alternative treatments or newer devices designed to resist radiation-related malfunction. The heightened awareness of this issue among providers and patients could temper growth for conventional cardiac rhythm devices, particularly in oncology-related care settings. As technology evolves, market players will need to address this concern through innovations that ensure device resilience in radiation-intensive environments.
Key Market Trends
Rising Demand for Minimally Invasive Procedures
The growing preference for minimally invasive cardiac procedures is driving increased utilization of cardiac monitoring and rhythm management devices. These less invasive approaches reduce recovery time, hospital stays, and procedural risks, making them attractive for both patients and providers.
Devices such as pacemakers, ICDs, and CRTs are integral to these procedures, enabling real-time heart rhythm regulation and monitoring. The trend aligns with the broader movement toward outpatient care and day surgeries, which are becoming more common in cardiology. As the healthcare system emphasizes patient-centered, cost-effective solutions, minimally invasive interventions are anticipated to significantly support market expansion for cardiac monitoring and rhythm management technologies.
Key Market Players
• Abbott Laboratories, Inc.
• Medtronic USA, Inc.
• Boston Scientific Corporation
• GE Healthcare
• Philips Healthcare (USA)
• Hill-Rom Holdings, Inc.
• BIOTRONIK, Inc.
• Alivecor, Inc.
Report Scope:
In this report, the United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Product Type:
o Cardiac Monitoring Devices
o Cardiac Rhythm Management Device
• United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By End User:
o Hospitals & Clinics
o Cardiac Care Centers
o Ambulatory Surgery Centers
o Others
• United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market, By Region:
o Northeast Region
o Midwest Region
o West Region
o South Region
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market.
Available Customizations:
United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Cardiac Monitoring Devices, Cardiac Rhythm Management Device)
5.2.2. By End User (Hospitals & Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. Northeast Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By End User
7. Midwest Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By End User
8. South Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By End User
9. West Cardiac Monitoring & Cardiac Rhythm Management Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By End User
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Policy & Regulatory Landscape
13. United States Economic Profile
14. United States Cardiac Monitoring & Cardiac Rhythm Management Devices Market: SWOT Analysis
15. Competitive Landscape
15.1. Abbott Laboratories, Inc.
15.1.1. Business Overview
15.1.2. Product & Service Offerings
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. Financials (If Listed)
15.1.6. SWOT Analysis
15.2. Medtronic USA, Inc.
15.3. Boston Scientific Corporation
15.4. GE Healthcare
15.5. Philips Healthcare (USA)
15.6. Hill-Rom Holdings, Inc.
15.7. BIOTRONIK, Inc.
15.8. Alivecor, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer